-
The Platelia Aspergillus EIA for detecting Aspergillus galactomannan in blood has been recently approved by the Food and Drug Administration for use in the United States.
-
Pyrazinamide was the most frequent cause of drug-related adverse events, especially hepatitis, among patients with tuberculosis receiving first-line drugs.
-
The authors tested samples sent to stanford hospital microbiology laboratory for diagnosis of C. difficile infection (CDI).
-
Post-marketing surveillance outside the United States of the two FDA-licensed rotavirus vaccines, RotaTeq (Merck, licensed in 2006) and Rotarix (GSK Biologicals, licensed in 2008), have identified a very low but increased risk (1 case/100,000 vaccinated infants) of intussusception following Rotarix vaccination.
-
A structured search and analysis was conducted of all published articles describing historical and physical features of children with culture-confirmed bacterial meningitis.
-
Monkeypox is an orthopoxvirus related to variola, which causes a clinically similar (although less severe) illness to smallpox.
-
During the 2007-2008 and 2008-2009 influenza seasons, children ages 1-3 years, with influenza-like symptoms, were randomized to receive oseltamivir suspension vs. matching placebo for 5 days.
-
In this issue: Tiotropium for uncontrolled asthma, sibutramine pulled from market, incidence and mortality data from WHI, FDA Actions.
-
-
Central line-associated infections, particularly bloodstream infections (BSI), remain a huge issue in our technological age.
